Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma

31 Mar 2020

Abstract excerpt

Abstract Purpose: Adults with T-cell lymphoblastic lymphoma (T-LBL) generally benefit from treatment with acute lymphoblastic leukemia (ALL)-like regimens, but approximately 40% will relapse after such treatment. We evaluated the value of CpG methylation in predicting relapse for adults with T-LBL treated with ALL-like regimens. Experimental Design: A total of 549 adults with T-LBL from 27 medical centers were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Lymphoma Diagnosis and Treatment
Share to T-cell and Retrovirus Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32234760
DOI: 10.1158/1078-0432.ccr-19-4207

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic LymphomaPMID 32234760Read ↗

DNA methylation markers in the diagnosis and prognosis of common leukemiasSemantic proximity Read ↗

Refining risk prediction in pediatric acute lymphoblastic leukemia through DNA methylation profilingSemantic proximity Read ↗

Prognostic utility of Multiplex ligation-dependent probe amplification in Acute T cell lymphoblastic leukemia /T lymphoblastic lymphomaSemantic proximity Read ↗

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemiaSemantic proximity Read ↗

DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemiaSemantic proximity Read ↗

MIR4435-2HG as a Novel Predictive Biomarker of Chemotherapy Response and Death in Pediatric B-cell AllSemantic proximity Read ↗

Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemiaSemantic proximity Read ↗

Identification of monitoring panels and hub genes for heterogeneous relapse outcomes in acute lymphoblastic leukemiaSemantic proximity Read ↗

Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemiaSemantic proximity Read ↗

Multi-Omics Analysis of Acute Lymphoblastic Leukemia Identified the Methylation and Expression Differences Between BCP-ALL and T-ALLSemantic proximity Read ↗

DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma.Semantic proximity Read ↗

A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.